Download Prof. Timcheva, MD, PhD

Advances in diagnostic methods and drug treatment of solid
malignant tumors – news from ASCO 2017
Fifth Annual Scientific Conference of Bulgarian Association for Medical Oncology (BAMO)
and Bulgarian National Association of Oncology (BNAO) with international participation
Hotel Balkan, София
16th – 18th June 2017
Organising Committee:
Scientific Committee:
Prof. Timcheva,MD, PhD – Chairperson
Prof. Dr. Bobev, MD, DMSc
Prof. Str. Karanov,MD, PhD – Chairperson Prof. I. Hristozova, MD, PhD
М.Taushanova, MD, PhD – Chairperson
Prof. J. Rainov, MD, PhD
Т. Karanikolova, MD – Secretary
Prof. J. Grudeva, MD, PhD
Assoc.Prof.I.Mihailova, MD, PhD-Secr.
Assoc.Prof. Hr. Ganchev,MD, PhD
N. Velikova, MD – Secretary
Assoc. Prof. L. Dermendjieva, MD, PhD
Assoc. Prof. G.Grigorov, MD, PhD
Assoc. Prof. S. Hadjidekova, MD, PhD
Assoc. Prof. G. Kirova, MD, PhD
Assoc. Prof. M. Nikolov, MD, PhD
Assoc. Prof. R. Alexandrova , MD, PhD
Assoc. Prof . R. Kaneva, DB, PhD
Assoc. Prof. Iv. Shterev, MD, PhD
Dr. G. Stamenov, MD, PhD
Dr. M. Petrova, MD
Dr. B. Krastev, MD
Dr. El. Krasteva , MD
Dr. Kr. Koinov, MD
1
Members of the Organising Committee:
Prof. J. Raynov, MD, PhD
N. Miteva, MD
M. Koleva, MD
Sp. Valev, MD
B. Dimitrov, MD
16.06.2017 Friday
08:00 – 19:00 Registration
14:30 – 15:30 Scientific symposium Astelas:
Treatment of mCRPC – from the international guidelines
to the everyday clinical practice
Moderatore: Kr. Koinov, MD
14:30 -14:50 Testosterone levels – significans and factor in the treatment of
mCRPC - K. Genova, MD
14:50-15:10 Hormonal treatment of mCRPC – guidelines and reality
R. Mangaldjiev, MD
15:10-15:30 Discussion
15:30– 16:00 Opening ceremony
Session I Advances in the surgical and radiation treatments of solid
malignant tumors. Epigenetics and cancer
2
Moderators: Assoc. Prof. R. Kaneva, DB, Assoc. Prof. G. Grigorov, MD, PhD
16:00 – 16:30 Primary and metastatic liver tumors – surgical treatment
opportunities
Prof. V. Dimitrova, MD, DMSc
16:30 – 17:00 Malignant spinal cord tumors – possibilities for treatment
Assoc. Prof. V. Gerganov, Leitender Oberarzt Neurochirurgie
INI Klinik , Hannover – Germany
17:00 – 17:30 Epigenetics and cancer
Prof. Claire VOURC'H PhD,
Proffesor at University Grenoble Alpes
RNA & Epigenetics,
Institute for Advanced Biosciences (IAB), France
17:30 – 18:00 ASCO 2017 and radiotherapy of malignant tumors
Assoc. Prof. I. Mihailova, MD, PhD
18:00 – 18:15 Discussion
18:15 – 19:15 Scientific symposium AstraZeneca:
We can transform now the treatment of patients with ovarian cancer
Moderator: Prof. K. Timcheva, MD, PhD
1. Assoc. Prof. R. Kaneva, Molecular Medicine Center, Medical
University, Sofia
2. Prof. Dr Nicoletta Colombo PhD , Director, Division of Medical
Gynecologic Oncology, European Institute of Oncology, Milan
3. Discussion
20:00
Official dinner
3
18.06.2016
Saturday
Session II Advances in the treatment of lung cancer
Moderators: Assoc. Prof. G. Kirova, MD, PhD,
Assoc. Prof. Hr. Ganchev, MD, PhD
9:00 – 9:30 Immunotherapy of NSCLC - does immunotherapy apply for all
NSCLC patients?
Dr. Raffaelle Califano - Consultant In Medical Oncology at The
Christie NHS Foundation Trust and University Hospital of South
Manchester, UK
9:30 – 9:55 Avastin plus Tarceva in the treatment of NSCLC – news from
ASCO 2017. Presentation sponsored by Roche - Bulgaria
ТВС
9:55 – 10:15 Estimation of radiology response of lung cancer treatment in the era
of genomic medicine
М. Penkov, MD – St. Iv. Rilski Hospital, Sofia
10:15 – 10:30 Discussion
10:30 – 11:30 Scientific Symposium Boehringer-Ingelheim
11:30 – 12:30 Lunch
Session III Drug treatment of breast cancer - what’s new at ASCO 2017?
Moderators: El. Krasteva, MD, Assoc. Prof. M. Nikolov, MD, PhD
12:30 – 13:00 ASCO 2017 update on HER2/HR-positive breast cancer
Prof. Tanja Cufer, MD, PhD
Professor of Oncology, University Clinic Golnik
Medical Faculty Ljubljana
4
13:00 – 13:30 Unmet medical needs in adjuvant treatment of HER2 positive
Breast Cancer. Scientific medical presentation sponsored by Roche
Bulgaria – EOOD
ТВС
13:30 – 14:00
Palbocyclib for the treatment of metastatic Breast Cancer with
hormonal sensitivity
Prof. Timcheva, MD, PhD
14:00 – 14:30
Halaven – the present and the future
М. Taushanova, MD, PhD
14:30 – 14:40
Discussion
14:40 – 15:10 Coffee break
Session ІV Fertility preservation of patients with oncology diseases
Moderators: M. Taushanova, MD, PhD, Assoc. Prof. Baltadjieva, MD, PhD
15:10 - 15:30 Cryoconservation for fertility preservation of oncology patients
- an investment in the future
St. Nikolova, MHAT “Nadezhda”
15:30 – 16:00 National Consensus for Fertility preservation of oncology patients
G. Stamenov, MD, PhD
16:00 – 16:10 Discussion
Session V
Session for young medical oncologists
Moderators: M. Petrova, MD, R. Krasteva, MD
А. Colorectal cancer
16:10 – 16:40 Right colon - does it matter when deciding treatment approach in
metastatic setting?
Prof. Erica Martinelli, MD, PhD, U.O.C. Oncologia Medica ed
5
Ematologia, Dipartimento Medico-Chirurgico di Internistica
Clinica e Sperimentale “F. Magrassi e A. Lanzara”, Naples
16:40 – 16:55 Clinical case N1
16:55 – 17:10 Clinical case N2
17:10 – 17:25 Clinical case N3
17:25 – 17:40 Discussion
B.
Bulgarian scientific projects
17:40 –17:55 Elisaveta Dimitrova, MD
17:55 - 18:10 Nikolay Tsonev, MD
18:10 –18:25 Boris Krastev, MD
18:25 - 18:45 Discussion
18:45 – 19:45 Scientific symposium Eli Lilly
20:00
Dinner
18.06.2017 Sunday
Сесия VІ Contemporary achievements in the treatment of gastrointestinal
malignant tumors
Moderators: Prof. J. Rainov, MD, PhD, N.Miteva, MD
08:30 – 09:00 Pharmacological vigilance during application of biosimilars.
Presentation sponsored by Roche Bulgaria.
ТВС
09:00 -09:25 Avastin in the treatment of colorectal cancer. Presentation spon sored by Roche Bulgaria
ТВС
6
09:25 – 09:55 First line treatment of patients with WT RAS metastatic colorectal
cancer - additional data, therapeutic considerations and possibilities supporting treatment decisions
Kr. Koynov, MD
09:55 – 10:05 Discussion
10:05 – 10:20 Coffee break
Session VIІ Achievements in the drug management of skin malignant
tumors
Moderators: М. Коleva, MD, T. Karanikolova, MD
10:20 – 10:50 Longterm efficacy of combination Cotellic and Zelboraf
in the treatment of inoperable or metastatic malignant melanoma
with BRAF V600 mutation. Presentation sponsored by Roche
Bulgaria
ТВС
10:50 – 11:50 Scientific symposium Novartis: new treatment options for metastatic malignant melanoma
11:50 -12:00 Discussion
Session VIІІ Recent advances in the treatment of ovarian malignant
tumors. Renal cell carcinoma
Moderators: Assoc. Prof. S. Hadjidekova, Sp. Valev, MD
12:00-12:30
NGS of gene panels for diagnostics of familial oncology diseases
At. Mitkova, DB
12:30 – 12:50 Ovarian cancer - new conception for the origin and staging
- FIGO 2014, AJCC-2016
Prof. S. Popovska, MD, DMSc
7
12:50 – 13:20 What new in the treatment of RCC?
TBC
13:20 – 13:30 Discussion
13:30 - 13:40 Proposals for BAMO 2018
13:40 – 13:50 Closure remarks
13:50 Lunch
8